A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus

Vaccine

Volumn 25, Issue 6, 2007, Pages 1064-1070

  Lazo, Laura ^a   Hermida, Lisset ^a   Zulueta, Aída ^a   Sánchez, Jorge ^a   López, Carlos ^a   Silva, Ricardo ^a   Guillén, Gerardo ^a   Guzmán, María G ^b  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Capsid; Cellular response; Core; Dengue virus; Vaccine

Indexed keywords

CAPSID PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DENGUE; DENGUE VIRUS; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

ANIMALS; CAPSID PROTEINS; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; DENGUE; DENGUE VACCINES; DENGUE VIRUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; VACCINES, DNA;

EID: 33845601324     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.068     Document Type: Article

References (37)

1. Aihara H., Takasaki T., Matsutani T., Suzuki R., and Kurane I. Establishment and characterization of japanese encephalitis virus-specific human CD41 T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. J Virol 72 (1998) 8032-8036
2. Berrios V., Kurane I., and Ennis F.A. Immunomodulatory effects of IL-7 on dengue virus-specific cytotoxic CD4+ T cell clones. Immunol Invest 25 3 (1996) 231-240
3. Bullock W.O., Fernández J.M., and Short J.M. XL1-blue: A high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection. Biotechniques 4 (1987) 376-378
4. Chambers T.J., Chang S., Galler R., and Rice C. Flavivirus genome organization, expression and replication. Annu Rev Microbiol 44 (1990) 649-688
5. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
6. Costa S.M., Paes M., Barreto D., Pinhao A., Barth O., Queiroz J.L., et al. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding he non-structural 1 gene fused to the tissue plasminogen activator signal sequence. Vaccine 24 (2006) 195-205
7. Deubel V., Kinney R.M., and Trent D.W. Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus. Jamaica Genotype Virol 155 (1986) 365-377
8. Dueñas-Carrera S., Alvarez-Lajonchere L., Alvarez-Obregon J.C., Herrera A., Lorenzo L.J., Pichardo D., et al. A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization. Vaccine 7-8 (2000) 992-997
9. Gagnon S.J., Ennis F.A., and Rothman A.L. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 73 5 (1999) 3623-3629
10. Gagnon S.J., Zeng W., Kurane I., and Ennis F.A. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones. J Virol 70 (1996) 141-147
11. Green S., Kurane I., Edelman R., Tacket C.O., Eckels K.H., Vaughn D.W., et al. Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. J Virol 67 10 (1993) 5962-5967
12. Gubler D.J., and Kuno G. Viral pathogenesis of dengue infections. In: Gubler D.J., and Kuno G. (Eds). Dengue and dengue hemorragic fever (1997), CAB International 273-275
13. Guzman M.G., Deubel V., Pelegrino J.L., Rosario D., Marrero M., Sariol C., et al. Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. Am J Trop Med Hyg 52 3 (1995) 241-246
14. Halstead S.B., and O'Rourke E.J. Dengue viruses and mononuclear phagocytes Infection enhancement by non-neutralizing antibody. J Exp Med 146 (1977) 201-229
15. Hermida L., Bernardo L., Martín J., Alvarez M., Prado I., López C., et al. A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine 24 16 (2006) 3165-3171
16. Hermida L., Rodri{dotless}guez R., Lazo L., Silva R., Zulueta A., Chinea G., et al. A dengue-2 envelope fragment inserted within the structure of the P64k meningococcal protein carrier, enables a functional immune response against the virus in mice. J Virol Methods 115 (2004) 41-49
17. Jones C.T., Ma L., Burgner J.W., Groesh T.D., Post C.B., and Kuhn R.J. Flavivirus capsid is a dimeric alpha-helicoidal protein. J Virol 77 (2003) 7143-7149
18. Kiermayr S., Kofler M., Mandl C., Messner P., and Heinz F.X. Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly af capsid like particles. J Virol 78 (2004) 8078-8084
19. Kuhn R.Y., Zhang W., Rossman M.G., Pletnev S.V., Corver J., Lenches E., et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108 (2002) 717-725
20. Lin C.F., Chiu S.C., Hsiao Y.L., Wan S.W., Lei H.Y., Shiau A.L., et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein. J Immunol 174 1 (2005) 395-403
21. Lin C.F., Wan S.W., Cheng H.J., Lei H.Y., and Lin Y.S. Autoimmune pathogenesis in dengue virus infection. Viral Immunol 19 2 (2006) 127-132
22. Lorenzo L., Dueñas-Carrera S., Falcon V., Acosta-Rivero N., Gonzalez E., De la Rosa M.C., et al. Assembly of truncated HCV core antigen into virus-like particles in E. coli. Biochem Biophys Res Común 281 4 (2001) 962-965
23. Ma L., Jones C.T., Groesch T.D., Kuhn R.J., and Post C.B. Solution structure of dengue virus capsid protein reveals another fold. Proc Natl Acad Sci USA 101 (2004) 3414-3419
24. Mandl C.V., Heinz F.X., and Kunz C. Sequence of structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology 166 (1988) 197-205
25. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9 7 (2003) 921-927
26. Mongkolsapaya J., Duangchinda T., Dejnirattisai W., Vasanawathana S., Avirutnan P., Jairungsri A., et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol 176 6 (2006) 3821-3829
27. Sambrook J., Fritsch E.F., and Maniatis T. In: Irwin N., Ford N., Nolan C., Ferguson M., and Ockler M. (Eds). The molecular cloning. A laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York Co.
28. Sanger F., Niclen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74 (1977) 5463-5467
29. Sousa C.R., and Germain N.R. Mayor histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocitocis. J Exp Med 182 (1995) 241-251
30. Tadano M., Fukunaga Y., Okuno T., and Fukai K. Detection of dengue 4 virus core protein in the nucleus. I. A monoclonal antibody to dengue 4 virus reacts with the antigen in the nucleus and cytoplasm. J Gen Virol 70 (1989) 1409-1415
31. Tleugabulova D., Falcon V., and Penton E. Evidence for the denaturation of recombinant hepatitis B surface antigen on aluminium hydroxide gel. J Chromatogr B Biomed Sci Appl 720 (1998) 153-163
32. Van Der Most R.G., Murali-Krishna K., Ahmed R., and Strauss J.H. Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response. J Virol 74 (2000) 8094-8101
33. Westaway E.G., and Blok J. Taxonomy and evolutionary relationships of flaviviruses. In: Gubler D.J., and Kuno G. (Eds). Dengue and dengue hemorrhagic fever (1997), CAB International, Wallingford England 147-173
34. Winkler G., Randolph V.B., and Cleaves G.R. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162 (1988) 187-196
35. Xing Y.P., Huang Z.H., Wang S.X., Cai J., Li J., Chou T.H., et al. Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice. World J Gastroenterol 29 (2005) 4583-4586
36. Zhang W., Chipman P.R., Corver J., Johnson P.R., Zhang Y., Mukhopadhyay S., et al. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10 11 (2003) 907-912
37. Zivny J., DeFronzo M., Jarry W., Jameson J., Cruz J., Ennis F.A., et al. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. J Immunol 163 5 (1999) 2754-2760